Finance

Lists
ORGO:NASDAQ
Organogenesis Holdings Inc
0,86 USD
+1,81%
(+0,015) 1D
6-ноя., 15:31:22 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ORGO...
Open
0,78 USD
High
0,91 USD
Low
0,75 USD
Mkt. cap
110,52 млн
Avg. vol.
956,74 миң
Volume
620,15 миң
52-wk high
7,08 USD
52-wk low
0,73 USD
EPS
-0,85 USD
Beta
1,48
Shares outstanding
128,68 млн
No. of employees
525
Open
0,78 USD
High
0,91 USD
Low
0,75 USD
Mkt. cap
110,52 млн
Avg. vol.
956,74 миң
Volume
620,15 миң
52-wk high
7,08 USD
52-wk low
0,73 USD
EPS
-0,85 USD
Beta
1,48
Shares outstanding
128,68 млн
No. of employees
525
News stories
From web sources and news partners
The Globe and Mail
The Globe and Mail
·
10 саат мурун
Organogenesis (ORGO) Q3 2026 Earnings Call Transcript
Yahoo Finance
Yahoo Finance
·
16 саат мурун
Organogenesis Q3 Earnings Call Highlights
Benzinga
Benzinga
·
21 саат мурун
Organogenesis Holdings Q3 2026 Earnings Call Transcript
Investing.com
Investing.com
·
21 саат мурун
Organogenesis Holdings earnings missed by $0.07, revenue fell short of estimates
About Organogenesis Holdings Inc
CEOGary S. Gillheeney Sr.
Employees525
Founded-
HeadquartersКантон, Массачусетс, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websiteinvestors.organogenesis.com
Analyst ratings
Based on 2 analysts giving stock ratings to ORGO in the past 3 months
Hold
Buy
0
Hold
2
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for ORGO in the last 3 months.
Highest
Current 0,86 USD
2,00 USD (+133,89%)
Average
2,00 USD (+133,89%)
Lowest
2,00 USD (+133,89%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
11/05/2026
Ravi Misra
Truist Financial
Hold
Maintained
2,00 USD
+133,9%
08/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
150,86 млн
225,61 млн
37,23 млн
43,76 млн
Cost of goods sold
36,25 млн
44,74 млн
25,77 млн
23,67 млн
Cost of revenue
36,25 млн
44,74 млн
25,77 млн
23,67 млн
Research and development expenses
13,22 млн
10,29 млн
15,16 млн
18,30 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
79,23 млн
100,17 млн
65,19 млн
53,96 млн
Operating expense
92,45 млн
110,46 млн
80,35 млн
72,26 млн
Total operating expenses
128,70 млн
155,20 млн
106,12 млн
95,94 млн
Operating income
22,16 млн
70,41 млн
-68,89 млн
-52,18 млн
Other non operating income
18,00 миң
-98,00 миң
38,00 миң
-26,00 миң
EBT including unusual items
21,16 млн
63,43 млн
-68,47 млн
-50,88 млн
EBT excluding unusual items
22,60 млн
70,55 млн
-68,47 млн
-52,07 млн
Income tax expense
-407,00 миң
19,73 млн
-15,32 млн
45,39 млн
Effective tax rate
-1,92%
31,10%
22,37%
-89,20%
Other operating expenses
-
-
-
-
Net income
21,57 млн
43,70 млн
-53,16 млн
-96,27 млн
Net profit margin
14,30%
19,37%
-142,78%
-220,01%
Earnings per share
0,18
0,40
-0,34
-0,69
Interest and investment income
415,00 миң
236,00 миң
380,00 миң
138,00 миң
Interest expense
-
-
-
-
Net interest expenses
415,00 миң
236,00 миң
380,00 миң
138,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
27,04 млн
75,27 млн
-63,91 млн
-48,10 млн
Gain or loss from assets sale
951,00 миң
2,06 млн
-
-793,00 миң
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору